You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
港股異動丨新冠疫情再抬頭,相關概念股集體上升,康希諾、君實生物升超8%
港股市場新冠概念股集體上升,其中,康希諾、先聲藥業、歌禮制藥、君實生物均升超8%,晶泰控股、石藥集團、復星醫藥、騰盛博藥等跟升。消息面上,曾肆虐全球的新冠病毒近日在兩岸三地再度活躍。據中國疾控中心的監測資料顯示,從今年3月31日至5月4日,全國門診流感樣病例中新冠陽性率從7.5%增加至16.2%,住院病例新冠陽性率亦從3.3%增加至6.3%。在台灣,相關部門表示,台灣新冠疫情持續上升,今年5月11日至17日,門急診達19097人次,較前一週上升88.2%。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account